AnalystsDavid NierengartenDavid Nierengarten's Stock Forecasts
AnalystsDavid Nierengarten
Sectors:
Industries:
Analyst Ranking
Top 5%
#228 out of 5067 analysts
Average Return
+14.52%
Win Rate
50%103 out of 205
Risk vs Reward
Poor
Good
David Nierengarten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Chimerix IncCMRX | +870.45% | $0.88 | $8.54 | 2024-11-18 - 2025-04-17 | Buy |
Anaptysbio IncANAB | +405.93% | $23.10 | $116.87 | 2017-03-09 - 2018-03-09 | Buy |
Fusion Pharmaceuticals IncFUSN | +382.46% | $4.39 | $21.18 | 2023-06-28 - 2024-03-19 | Buy |
G1 Therapeutics IncGTHX | +352.53% | $1.58 | $7.15 | 2023-10-30 - 2024-09-17 | Buy |
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-02 - 2021-03-02 | Buy |
David Nierengarten Analyst Color
Get additional color on David Nierengarten's coverage of popular stocks
David Nierengarten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Anaptysbio IncANAB | 12 | Buy | $70.00 | +103.49% | Maintains | 3 days ago |
Argenx SeARGX | 21 | Buy | $880.00 | +5.10% | Maintains | 5 days ago |
Kiniksa Pharmaceuticals International PLCKNSA | 4 | Buy | $44.00 | +13.05% | Maintains | 5 days ago |
Nuvation Bio IncNUVB | 11 | Buy | $6.00 | +65.29% | Reiterates | 5 days ago |
Nuvalent IncNUVL | 6 | Buy | $115.00 | +27.18% | Reiterates | a month ago |
Shattuck Labs IncSTTK | 1 | Buy | $4.00 | +122.22% | Initiates Coverage On | a month ago |
Xencor IncXNCR | 8 | Buy | $26.00 | +73.91% | Reiterates | 2 months ago |
Telix Pharmaceuticals LtdTLX | 3 | Buy | $22.00 | +102.58% | Reiterates | 2 months ago |
Generation Bio CoGBIO | 9 | Hold | $7.00 | +5.42% | Downgrades | 2 months ago |
Imagenebio IncIMA | 5 | Hold | $276.00 | +3,536.36% | Maintains | 3 months ago |
Vor Biopharma IncVOR | 7 | Hold | $8.00 | -72.47% | Reiterates | 4 months ago |
Perspective Therapeutics IncCATX | 4 | Buy | $11.00 | +131.58% | Reiterates | 4 months ago |
Blueprint Medicines CorpBPMC | 5 | Hold | $129.00 | -0.36% | Downgrades | 5 months ago |
Iteos Therapeutics IncITOS | 3 | Hold | $12.00 | +18.23% | Downgrades | 5 months ago |
Intellia Therapeutics IncNTLA | 7 | Hold | $10.00 | -59.86% | Reiterates | 5 months ago |
Novocure LtdNVCR | 5 | Hold | $27.00 | +92.44% | Maintains | 6 months ago |
Immunome IncIMNM | 6 | Buy | $33.00 | +100.12% | Reiterates | 7 months ago |
Sutro Biopharma IncSTRO | 7 | Hold | $2.00 | +127.01% | Downgrades | 7 months ago |
Fate Therapeutics IncFATE | 13 | Hold | $5.00 | +224.68% | Reiterates | 7 months ago |
Bicara Therapeutics IncBCAX | 2 | Buy | $31.00 | +65.95% | Reiterates | 8 months ago |
Springworks Therapeutics IncSWTX | 3 | Buy | $77.00 | +63.86% | Reiterates | 8 months ago |
Apogee Therapeutics IncAPGE | 3 | Buy | $90.00 | +68.54% | Maintains | a year ago |
Scholar Rock Holding CorpSRRK | 7 | Buy | $47.00 | +59.65% | Maintains | a year ago |
Chimerix IncCMRX | 3 | Buy | $6.00 | -29.74% | Reiterates | a year ago |
Inozyme Pharma IncINZY | 6 | Buy | $15.00 | N/A | Reiterates | a year ago |
Y Mabs Therapeutics IncYMAB | 3 | Buy | $23.00 | N/A | Reiterates | a year ago |
Oric Pharmaceuticals IncORIC | 7 | Buy | $20.00 | N/A | Reiterates | a year ago |
Oruka Therapeutics IncORKA | 1 | Buy | $40.00 | N/A | Initiates Coverage On | a year ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Tscan Therapeutics IncTCRX | 4 | Buy | $10.00 | N/A | Reiterates | a year ago |
Artiva Biotherapeutics IncARTV | 1 | Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Disc Medicine IncIRON | 3 | Buy | $57.00 | N/A | Reiterates | a year ago |
2seventy Bio IncTSVT | 8 | Hold | $5.00 | N/A | Reiterates | a year ago |
Cogent Biosciences IncCOGT | 3 | Hold | $10.00 | N/A | Reiterates | a year ago |
Prime Medicine IncPRME | 3 | Buy | $12.00 | N/A | Reiterates | a year ago |
Beam Therapeutics IncBEAM | 3 | Buy | $57.00 | N/A | Reiterates | a year ago |
Fusion Pharmaceuticals IncFUSN | 4 | Hold | $24.00 | N/A | Downgrades | 2 years ago |
Bluebird Bio IncBLUE | 1 | Hold | $33.60 | N/A | Maintains | 2 years ago |
Mersana Therapeutics IncMRSN | 2 | Buy | $175.00 | N/A | Upgrades | 2 years ago |
G1 Therapeutics IncGTHX | 6 | Buy | $4.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 4 | Hold | $2.00 | N/A | Reiterates | 2 years ago |
Maxeon Solar Technologies LtdMAXN | 1 | Hold | $500.00 | N/A | Maintains | 2 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Karyopharm Therapeutics IncKPTI | 6 | Hold | $60.00 | N/A | Maintains | 2 years ago |
Theseus Pharmaceuticals IncTHRX | 2 | Buy | $7.00 | N/A | Maintains | 2 years ago |
Tectonic Therapeutic IncTECX | 1 | Hold | $24.00 | N/A | Downgrades | 2 years ago |
Iveric Bio IncISEE | 3 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Fennec Pharmaceuticals IncFENC | 3 | Buy | $19.00 | N/A | Maintains | 3 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 1 | Hold | $76.00 | N/A | Downgrades | 3 years ago |
Codiak Biosciences IncCDAKQ | 1 | Buy | $24.00 | N/A | Maintains | 4 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Hold | $11.00 | N/A | Downgrades | 4 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Stemline Therapeutics IncSTML | 3 | Hold | $12.50 | N/A | Downgrades | 5 years ago |
Syros Pharmaceuticals IncSYRS | 3 | Hold | $90.00 | N/A | Downgrades | 6 years ago |
Tesaro IncTSRO | 3 | Hold | $75.00 | N/A | Downgrades | 7 years ago |
Spark Therapeutics IncONCE | 2 | Hold | $40.00 | N/A | Upgrades | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 6 | Buy | $88.00 | N/A | Maintains | 7 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $52.00 | N/A | Maintains | 7 years ago |
Endocyte IncECYT | 3 | Buy | $21.00 | N/A | Maintains | 7 years ago |
Voyager Therapeutics IncVYGR | 2 | Buy | N/A | N/A | Upgrades | 7 years ago |
Prothena Corp Public Ltd CoPRTA | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Kite Pharma IncKITE | 2 | Hold | N/A | N/A | Upgrades | 8 years ago |
Juno Therapeutics IncJUNO | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Clementia Pharmaceuticals IncCMTA | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.